ClinVar Miner

Submissions for variant NM_001018005.2(TPM1):c.840T>C (p.Asp280=)

gnomAD frequency: 0.00001  dbSNP: rs749271066
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV001119718 SCV001278149 uncertain significance Hypertrophic cardiomyopathy 3 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Illumina Laboratory Services, Illumina RCV001119719 SCV001278150 uncertain significance Dilated cardiomyopathy 1Y 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Color Diagnostics, LLC DBA Color Health RCV001192109 SCV001360085 likely benign Cardiomyopathy 2018-12-31 criteria provided, single submitter clinical testing
Invitae RCV001495214 SCV001699885 likely benign Hypertrophic cardiomyopathy 2024-01-15 criteria provided, single submitter clinical testing
GeneDx RCV001593282 SCV001814387 likely benign not provided 2021-05-13 criteria provided, single submitter clinical testing
Ambry Genetics RCV002445390 SCV002679380 uncertain significance Cardiovascular phenotype 2024-05-06 criteria provided, single submitter clinical testing The c.840T>C variant (also known as p.D280D), located in coding exon 9 of the TPM1 gene, results from a T to C substitution at nucleotide position 840. This nucleotide substitution does not change the aspartic acid at codon 280. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
PreventionGenetics, part of Exact Sciences RCV003963064 SCV004790166 likely benign TPM1-related disorder 2019-03-26 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
All of Us Research Program, National Institutes of Health RCV001495214 SCV004815471 likely benign Hypertrophic cardiomyopathy 2024-02-05 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.